1. Pôle de Recherche Cardiovasculaire, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels, Belgium;
2. Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom;
3. Division of Endocrinology and Metabolism, Departments of Medicine and Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada;
4. St. Vincent’s Institute of Medical Research and Department of Medicine, University of Melbourne, Fitzroy, VIC, Australia;
5. Mary MacKillop Institute for Health Research, Australian Catholic University, Fitzroy, VIC, Australia;
6. Laboratory of Thrombosis and Hemostasis and Valvular Heart Disease, Grappe Interdisciplinaire de Génoprotéomique Appliquée–Cardiovascular Sciences, Department of Cardiology, Université de Liège, CHU Sart-Tilman, Liège, Belgium;
7. Department of Biochemistry, Cardiovascular Research Institute Maastricht, University of Maastricht, Maastricht, The Netherlands;
8. Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands;
9. Department of Pathology, University of Alabama at Birmingham Mitochondrial Medicine Laboratory, Center for Free Radical Biology, University of Alabama at Birmingham, Birmingham, AL;
10. Centre de Technologies Moléculaires Appliquées, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels, Belgium;
11. Department of Parasitology and
12. Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands; and
13. Division of Cardiology, Cliniques Universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium